RAIDS Final Event
19 May 2017 - 19 May 2017
Paris, France
This final event will present an overview of the challenges, past and future, for precision medicine as well as offer a day of presentations by various speakers addressing topics including: ‘Tumour Profiling’, ‘Immunotherapy’ and ‘HPV Etiology’.
The RAIDs project (Rational molecular Assessments and Innovative Drugs selection) is an EU funded project which has developed intelligent new targeted therapy for HPV-related cervical cancer based on an understanding of specific wiring errors in tumour cell signalling. It sets the stage for future precision medicine and vaccine development through a comprehensive analysis of the tumour and interactions with its micro environment.
For more information, please see:
project webpage
The RAIDs project (Rational molecular Assessments and Innovative Drugs selection) is an EU funded project which has developed intelligent new targeted therapy for HPV-related cervical cancer based on an understanding of specific wiring errors in tumour cell signalling. It sets the stage for future precision medicine and vaccine development through a comprehensive analysis of the tumour and interactions with its micro environment.
For more information, please see:
project webpage